Mouwasat Medical Services Company (4002.SR) — Financial statements
Income statement, balance sheet, and cash flow for Mouwasat Medical Services Company — annual and quarterly history with growth and margin analysis.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 3,223↑11.9% | 2,879↑6.4% | 2,706↑15.9% | 2,334↑8.9% | 2,144 | |
| Cost of Revenue | 1,913↑20.3% | 1,590↑12.7% | 1,411↑14.2% | 1,235↑7.6% | 1,148 | |
| Gross Profit | 1,309↑1.6% | 1,289↓0.4% | 1,295↑17.8% | 1,099↑10.4% | 996 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 98↑34.4% | 73↓17.4% | 88↑24.0% | 71↑37.7% | 52 | |
| Selling & Marketing Expenses | 36↑13.8% | 32↓10.3% | 35↑24.5% | 28↑5.4% | 27 | |
| SG&A Expenses | 134↑28.2% | 104↓15.4% | 123↑24.1% | 99↑26.6% | 78 | |
| Other Expenses | 306↓33.5% | 460 | 0.00↓100.0% | 336↑13.9% | 295 | |
| Operating Expenses | 440↓22.1% | 565↑5.0% | 538↑23.4% | 436↑16.6% | 374 | |
| Total Costs & Expenses | 2,342↑8.7% | 2,155↑10.6% | 1,949↑16.6% | 1,671↑9.8% | 1,522 | |
| Operating Results | ||||||
| Operating Income | 869↑20.0% | 724↓4.3% | 757↑14.1% | 663↑6.6% | 622 | |
| Depreciation & Amortization | 244↑2.7% | 238↑6.5% | 223↑18.5% | 189↑19.7% | 157 | |
| EBITDA | 1,114↑14.3% | 974↓2.3% | 997↑15.7% | 862↑10.6% | 779 | |
| EBIT | 869↑18.1% | 736↓4.8% | 774↑13.2% | 683↑9.8% | 622 | |
| Interest & Other Income | ||||||
| Net Interest Income | 3↑115.6% | -18↑53.8% | -40↓79.2% | -22↓183.2% | -8 | |
| Interest Income | 22↑87.3% | 12↑84.8% | 6↑1026.7% | 0.58↑78.8% | 0.32 | |
| Interest Expense | 20↓35.8% | 30↓34.4% | 46↑103.0% | 23↑179.1% | 8 | |
| Non-Operating Income | 0.00↑100.0% | -12↑28.2% | -17↓59.6% | -10 | 0.00 | |
| Other Income / Expenses | 14↑174.2% | -18↑37.9% | -30↓139.6% | -12↓221.0% | 10 | |
| Income Before Tax | 883↑25.1% | 706↓2.9% | 727↑10.1% | 660↑4.4% | 632 | |
| Income Tax Expense | 31↓14.0% | 36↓6.5% | 39↑40.3% | 28↑26.9% | 22 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 852↑27.2% | 670↓2.7% | 688↑10.5% | 623↑3.8% | 600 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 822↑27.3% | 646↓1.8% | 658↑9.7% | 599↑3.7% | 578 | |
| Bottom-Line Net Income | 822↑27.3% | 646↓1.8% | 658↑9.7% | 599↑3.7% | 578 | |
| EPS (Basic) | 4.11↑26.9% | 3.24↓1.5% | 3.29↑9.7% | 3.00↑3.8% | 2.89 | |
| EPS (Diluted) | 4.11↑26.9% | 3.24↓1.5% | 3.29↑9.7% | 3.00↑3.8% | 2.89 | |
| Weighted Average Shares | 200↑0.0% | 200↑0.0% | 200↑0.0% | 200↑0.0% | 200 | |
| Weighted Average Diluted Shares | 200↑0.0% | 200↑0.0% | 200↑0.0% | 200↑0.0% | 200 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.